Last updated: March 4, 2024
Sponsor: Indiana University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Retina
Diabetic Retinopathy
Treatment
Blood draw
Clinical Study ID
NCT05079399
11656
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ability to cooperate with imaging procedures.
- Health status: established type 2 diabetes
- No history of panretinal photocoagulation (PRP)
- No history of treatment with intravitreal agents for past 12 months
Exclusion
Exclusion Criteria:
- Previous or current malignancy
- Acute or chronic infection (HIV, hepatitis B or C, tuberculosis)
- Cerebral vascular accident or cerebral vascular procedure
- Current pregnancy
- History of organ transplantation
- Presence of a graft (to avoid any effect of the graft)
- History of previous vitrectomy
- Subjects with a history of age-related macular degeneration age-related maculardegeneration (AMD), glaucoma, uveitis, and branched or central vein occlusion.
Study Design
Total Participants: 192
Treatment Group(s): 1
Primary Treatment: Blood draw
Phase:
Study Start date:
January 01, 2022
Estimated Completion Date:
June 30, 2026
Connect with a study center
Spring Mill Clinic
Carmel, Indiana 46920
United StatesActive - Recruiting
Eskenazi Eye Clinic
Indianapolis, Indiana 46202
United StatesActive - Recruiting
Glick Eye Institute
Indianapolis, Indiana 46202
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.